Dr. Elena Vasquez grew up deaf in a world that never listened—until she learned to make it. Born to undocumented immigrants in East Los Angeles, Elena fought her way through MIT and Harvard Medical School on sheer brilliance and stubborn grit. Now, she stands on the edge of a miracle: a revolutionary gene therapy that could cure hereditary hearing loss, a breakthrough the FDA has just fast-tracked for approval. But miracles attract predators. Damien Cross is the cold, calculating CEO of Aphion Global, a pharmaceutical empire built on acquisitions and ruthlessness. When he learns of Elena's breakthrough, he doesn't see a cure—he sees a four-hundred-billion-dollar monopoly. His offer: buy her research. His terms: non-negotiable. His problem? Elena would rather burn her lab than hand it to a man who profits from suffering. Then the data breaches begin. Someone is using military-grade SMS blaster technology—fake cell towers that intercept communications—to steal Elena's encrypted research files. Her AI co-developer, an algorithm that helped design the therapy's genetic sequences, becomes the center of a landmark legal battle: when artificial intelligence writes the code that saves lives, who owns the cure? As corporate espionage closes in and courtroom warfare erupts, Elena and Damien are forced into an uneasy alliance. He has the resources to protect her. She has the technology he needs. But the attraction sparking between them is neither strategic nor safe. In a world where genes can be rewritten, love might be the one thing that can't be patented—or predicted. The Gene He Stole is a steamy, high-stakes billionaire romance woven with cutting-edge science, corporate intrigue, and the dangerous chemistry between a woman who creates miracles and the man who wants to own them.